Sponsor or institution
Clinical trials and research at Suzhou BlueHorse Therapeutics Co., Ltd.
As of November 12, 2026, Find a Trial lists 5 clinical trials run by Suzhou BlueHorse Therapeutics Co., Ltd. that are recruiting, in China. By phase: Phase 2 (2), Early Phase 1 (2), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1Country
Newest trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| LM103 (tumor-infiltrating lymphocytes) as adjuvant treatment after surgery for non-small cell lung cancer | Phase 2 | Guangzhou, Guangdong and 4 other locations | Recruiting | Mar 3, 2026 |
| LM103 treatment for advanced melanoma (Phase II) | Phase 2 | Beijing, Beijing Municipality and 15 other locations | Recruiting | Dec 30, 2025 |
| Evaluating a new injection combined with PD-1 for advanced solid tumors | Early Phase 1 | China, Tianjin Municipality | Recruiting | Nov 20, 2024 |
| Treatment of advanced solid tumors with LM303 injection | Early Phase 1 | Tianjin | Recruiting | Nov 19, 2024 |
| Treatment of advanced solid tumors with LM103 Injection | Phase 1 | Tianjin | Recruiting | May 9, 2022 |
All recruiting trials (5)
-
LM103 (tumor-infiltrating lymphocytes) as adjuvant treatment after surgery for non-small cell lung cancer
This trial will test whether giving LM103 (TILs) after surgery and prior PD‑1 antibody therapy helps people with resectable non‑small cell lung cancer stay cancer‑free longer.
-
LM103 treatment for advanced melanoma (Phase II)
This study will test whether LM103 tumor‑infiltrating lymphocytes (TIL) given with chemotherapy can help adults with advanced melanoma who have not responded to at least two prior treatments.
-
Evaluating a new injection combined with PD-1 for advanced solid tumors
This study is testing a new injection combined with PD-1 therapy to see if it can help people with advanced solid tumors that haven't responded to other treatments.
-
Treatment of advanced solid tumors with LM303 injection
This study is testing a new injection called LM303 to see if it can help people with advanced solid tumors, like melanoma and lung cancer, who haven't had success with other treatments.
-
Treatment of advanced solid tumors with LM103 Injection
This study is testing a new injection called LM103 to see if it can help people with advanced solid tumors like melanoma and lung cancer feel better after chemotherapy.
Quick answers
How many clinical trials run by Suzhou BlueHorse Therapeutics Co., Ltd. are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in China. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Early Phase 1: 2, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.